Loading…
MoonLake Immunotherapeutics is projected to rise to $24.72 by 2027, a +34% move from its current price of $18.44. MLTX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $17.87 | $18.44 | $19.02 | -0.01% |
| Aug 3 | $17.64 | $18.44 | $19.27 | -0.02% |
| Aug 4 | $17.46 | $18.44 | $19.46 | -0.03% |
| Aug 5 | $17.32 | $18.43 | $19.62 | -0.04% |
| Aug 6 | $17.19 | $18.43 | $19.77 | -0.04% |
| Aug 7 | $17.07 | $18.43 | $19.90 | -0.05% |
| Aug 8 | $16.96 | $18.43 | $20.02 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $16.96 | $18.43 | $20.02 | -0.06% |
| Week 2 | $16.38 | $18.42 | $20.70 | -0.12% |
| Week 3 | $15.95 | $18.41 | $21.24 | -0.19% |
| Week 4 | $15.59 | $18.39 | $21.71 | -0.25% |
| Week 5 | $15.28 | $18.38 | $22.12 | -0.31% |
| Week 6 | $15.00 | $18.37 | $22.50 | -0.37% |
| Week 7 | $14.75 | $18.36 | $22.86 | -0.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis.
The company was founded in 2021 and is headquartered in Zug, Switzerland.
MoonLake Immunotherapeutics trades under the symbol MLTX and is a clinical-stage biotechnology company with a focus on inflammatory diseases. The current price is $19.02 and the market cap is $1.59B, with a rank of 5366.
The forecast shows an upward price outlook, with a 2026 average of $19.02, 2027 $26.22, and 2030 $46.07, extending to 2040 at $148.59 and 2050 at $323.98. Max projections rise to $68.98 by 2030, $262.79 by 2040, and $632.35 by 2050.
Longer-term sentiment remains bullish with a path toward higher values and ROI, up to 1603.4% by 2050.
A major floor 13.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.3% away) — a key level to hold.
The nearest ceiling, 20.2% above — a clean break opens room to run.
A major ceiling 27.1% above — clearing it would confirm fresh momentum.
Key MLTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $18.88 | Sell | $18.78 | Sell |
| MA 10 | $19.08 | Sell | $19.01 | Sell |
| MA 20 | $19.34 | Sell | $19.18 | Sell |
| MA 50 | $19.07 | Sell | $18.96 | Sell |
| MA 100 | $18.24 | Buy | $18.75 | Sell |
| MA 200 | $16.17 | Buy | $21.12 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.25 | Neutral |
| Stoch RSI (14) | 7.92 | Buy |
| CCI (20) | -117.65 | Sell |
| Williams %R (14) | -96.43 | Info |
| MACD (12,26,9) | -0.15 | Sell |
| ROC (12) | -7.62 | Sell |
| Bollinger %B (20,2) | 0.12 | Neutral |
| Stochastic %K (14) | 3.57 | Buy |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | -0.61 | Sell |
| Ultimate (7,14,28) | 42.07 | Neutral |
| Momentum (10) | -1.24 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 18.49 | Sell |
| ADX (14) | 8.00 | Neutral |
| ATR (14) | 0.60 | Info |
The 30-day technical picture is bullish. RSI14 is 50, indicating neutral momentum, while the SMA50 is $18.91 and the SMA200 is $15.89.
Support sits at $17.49 and resistance at $22.16. The 30-day range spans from $15.46 to $23.40, and annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.17 | $18.44 | $23.70 | 0% | Neutral | |
| $19.45 | $24.72 | $33.37 | +34% | Bullish | |
| $24.50 | $32.17 | $45.29 | +74% | Bullish | |
| $28.65 | $38.67 | $56.25 | +110% | Bullish | |
| $30.95 | $42.79 | $63.98 | +132% | Bullish | |
| $34.23 | $48.38 | $74.07 | +162% | Bullish | |
| $36.44 | $52.57 | $82.21 | +185% | Bullish | |
| $37.45 | $55.07 | $87.79 | +199% | Bullish | |
| $49.84 | $74.66 | $121.14 | +305% | Bullish | |
| $59.35 | $90.48 | $149.22 | +391% | Bullish | |
| $81.23 | $134.24 | $237.00 | +628% | Bullish | |
| $153.11 | $291.46 | $567.73 | +14.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $11.17 | $18.44 | $22.08 | +0.00% |
| September 2026 | $14.98 | $17.80 | $21.80 | -3.48% |
| October 2026 | $15.27 | $18.29 | $22.68 | +2.77% |
| November 2026 | $15.73 | $18.96 | $23.74 | +3.65% |
| December 2026 | $15.48 | $18.76 | $23.70 | -1.03% |
Click any year to see its month-by-month MLTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MLTX could reach as high as $23.70, with a base case around $18.44 and support toward $11.17 — roughly 0% from $18.44. Price action looks broadly range-bound.
Expect MLTX to range from $19.45 to $33.37 through 2027. The $24.72 average target implies a +34% move from current prices. That is up +34% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MLTX price prediction for 2028 points to an average of $32.17 (low $24.50, high $45.29) — a potential gain of +74% on today's $18.44. Momentum favours further upside here.
In 2029, MLTX is projected to trade between $28.65 and $56.25, averaging $38.67 — a potential gain of +110% from today's $18.44. That is up +20% on the projected 2028 average. Buyers look set to stay in control over this stretch.
MoonLake Immunotherapeutics's 2030 outlook centres on $42.79, within a $30.95 to $63.98 range. That is up +11% on the projected 2029 average. That marks a +132% change versus current levels. Momentum favours further upside here.
By 2031, MLTX could reach as high as $74.07, with a base case around $48.38 and support toward $34.23 — roughly +162% from $18.44. Buyers look set to stay in control over this stretch.
Expect MLTX to range from $36.44 to $82.21 through 2032. The $52.57 average target implies a +185% move from current prices. That is up +9% on the projected 2031 average. Momentum favours further upside here.
The MLTX price prediction for 2033 points to an average of $55.07 (low $37.45, high $87.79) — a potential gain of +199% on today's $18.44. Buyers look set to stay in control over this stretch.
In 2034, MLTX is projected to trade between $49.84 and $121.14, averaging $74.66 — a potential gain of +305% from today's $18.44. That is up +36% on the projected 2033 average. Momentum favours further upside here.
MoonLake Immunotherapeutics's 2035 outlook centres on $90.48, within a $59.35 to $149.22 range. That is up +21% on the projected 2034 average. That marks a +391% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MLTX could reach as high as $237.00, with a base case around $134.24 and support toward $81.23 — roughly +628% from $18.44. Momentum favours further upside here.
Expect MLTX to range from $153.11 to $567.73 through 2050. The $291.46 average target implies a +14.8x move from current prices. That is up +117% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MLTX today (≈ 54.229935 MLTX) could be worth
$15,806.02
+$14,806.02 (+1481%) by 2050 · US Dollar
Based on the average projected MLTX price of $291.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLTXwould be worth at today's price.
$1,000 invested in MLTX on Jul 31, 2025 (≈ 19.825536 MLTX) would be worth
$365.58
-$634.42 (-63.4%) today · 0.37× · US Dollar
Based on a MLTX entry price of $50.44 vs. today's $18.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $19.02 | $969.51 | -3.0% |
| 1 month ago | $19.13 | $963.93 | -3.6% |
| 3 months ago | $16.73 | $1,102.21 | +10.2% |
| 6 months ago | $15.79 | $1,167.83 | +16.8% |
| 1 year ago | $50.44 | $365.58 | -63.4% |
| All time (5.0y) ago | $9.94 | $1,855.13 | +85.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLTX forecast.
Our base-case forecast reaches $37.00 around 2029.
Implied market cap at $37.00: $3.15B
The multi-year forecast shows a steady uptrend from 2026 onward. The 2026 forecast has a min of $11.17, an avg of $19.02, and a max of $24.52, with ROI of 0% and sentiment NEUTRAL.
By 2030, the avg is $46.07 with a max of $68.98 and an ROI of 142.2% with bullish sentiment.
By 2040, the avg rises to $148.59 with a max of $262.79 and an ROI of 681.2% with bullish sentiment. By 2050, the avg is $323.98 with a max of $632.35 and an ROI of 1603.4% with bullish sentiment.
These are estimates, not guarantees, and reflect projected paths based on the provided figures.
Tap a question to reveal the answer.
In 2030, the forecasted average price is $46.07 with a max of $68.98 and a min of $33.28, and an ROI of 142.2% with bullish sentiment.
The forecast shows bullish sentiment from 2027 onward, with the 2030 avg price at $46.07 and ROI of 142.2%, the 2040 avg at $148.59 with ROI 681.2%, and the 2050 avg at $323.98 with ROI 1603.4%. These are estimates and not guarantees.
Yes. The 2033 forecast shows a min of $40.94, an avg of $60.30, and a max of $96.29, with bullish sentiment.
The current price is $19.02.
The 30-day range is $15.46 to $23.40.
MoonLake Immunotherapeutics Community Discussion
0Share your MoonLake Immunotherapeutics price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.